Sign in
4

Changes in Ownership

Vivos Therapeutics, Inc. Filed Acc 0001493152-21-023354

Chief Executive Officer bought 5,000 shares at $4.31 ($21,550)

From the SEC's structured data for this filing

Trades in this filing

Huntsman Ronald Kirk · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-09-21 Purchase : show line 1 in the form +5,000 $4.31 $21,550 15,500 D
Open-market purchases · 5,000 sh · avg $4.31 · $21,550
Loading xslF345X03/ownership.xml…